Urvi M. Parikh

56 papers · 1.1k indexed citations

Immediate Impact

7 from Science/Nature 59 hit

Sub-graph 1 of 23

Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study

2025 Hit

Potential Clinical and Economic Impacts of Cutbacks in the President’s Emergency Plan for AIDS Relief Program in South Africa

2025 Hit

3 intermediate papers

Potential Impact and Cost-Effectiveness of Condomless-Sex–Concentrated PrEP in KwaZulu-Natal Accounting for Drug Resistance

2019

Molecular mechanisms of bidirectional antagonism between K65R and thymidine analog mutations in HIV-1 reverse transcriptase

2007

and 1 more

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Urvi M. Parikh	922	732	333	217	131	56	1.1k
Artur Ramos	903 1.0×	854 1.2×	312 0.9×	101 0.5×	82 0.6×	26	1.1k
Mackenzie L. Cottrell	873 0.9×	480 0.7×	363 1.1×	69 0.3×	110 0.8×	76	1.2k
Shannon Galvin	895 1.0×	603 0.8×	531 1.6×	295 1.4×	261 2.0×	35	1.4k
Maile Karris	594 0.6×	272 0.4×	372 1.1×	118 0.5×	115 0.9×	61	1.1k
Olivier Manigart	983 1.1×	933 1.3×	491 1.5×	141 0.6×	183 1.4×	21	1.4k
Silvina Masciotra	1.2k 1.3×	1.1k 1.4×	493 1.5×	65 0.3×	74 0.6×	51	1.4k
Omu Anzala	651 0.7×	653 0.9×	404 1.2×	85 0.4×	104 0.8×	54	1.1k
Natasha Samsunder	668 0.7×	363 0.5×	442 1.3×	260 1.2×	319 2.4×	60	1.2k
V. S. Kitchen	467 0.5×	313 0.4×	349 1.0×	326 1.5×	111 0.8×	33	1.2k
Jean-Louis Sankalé	751 0.8×	801 1.1×	297 0.9×	65 0.3×	72 0.5×	29	1.1k

Loading papers...